His blood pressure was 95/70 mmHg and heart rate was 77 bpm. There was no symptom of low cardiac output syndrome. On echocardiography at emergency unit, aortic valve was opening on each cardiac cycle. The ventricular septum was at the midline with normally functioning and positioned device. There was no sign of device thrombosis. His anticoagulation management was effective. He was using warfarin and acetylsalicylic acid and his international normalized ratio was 2.9. The other routine blood tests were within normal range. After the initial evaluation, the patient was transferred to the inpatient clinic and connected to the backup system controller. There was only one stop alarm recorded before admission to the emergency unit at home. It was decided that the patient would be followed until further diagnosis, while being connected to the backup system controller. After an hour, the pump stopped again, although there was no clinical deterioration and about 30 sec later, the device started to work spontaneously. We connected the patient to a different system controller, but the pump stop occurred while it was on the power module support, and few minutes later, it started to work again. We observed that the frequency of these start and stop periods increased with the body movements of the patient and while he was lying on his left side, the pump stop periods were seen less often. We considered that some body movements might cause electrical loss of contact between any part along the electrical system of the driveline. This stop and start periods occurred several times during follow-up. Chest and abdominal X-ray and computed tomography findings were normal and no lesion or break through the driveline and no visual abnormality of the device itself (Figure 1) was observed. A few days later, authorized staff arrived from the manufacturer"s technical service to the hospital and checked the device and connecting systems and decided to dissect the silicone cuff of the driveline. When they dissected the silicone cuff of the driveline, they found fluid inside the driveline and reported to us that it was technically not possible to fix this problem (Figure 2). When we re-evaluated the patient"s history, we found out that he died several times in a special outfit that he designed without our permission. We performed echocardiography, when the pump was stopped. Ejection fraction was 20% and left ventricular end-diastolic diameter was found to be 6.7 cm. Therefore, with these poor ventricular functions, the device removal would not have been the appropriate approach. The patient was informed about the two possible interventions: first was heart transplantation as soon as possible and the latter one was the exchange of the device. The patient's primary preference was heart transplantation. It was decided to take the patient on urgent transplantation list and two weeks later, the patient underwent a heart transplant.
Figure 1: Left and right panels of X-ray showing no visible lesions of driveline and device.
Currently, most of patients with end-stage heart failure may have dramatic improvement in their exercise capacity after LVAD support. In some occasions, patients may prefer LVAD implantation to heart transplantation or cannot receive heart transplant for specific reasons. Conditions such as swimming, diving, and similar hobbies are harmful for patients under LVAD support. On the other hand, these devices still have technical difficulties which complicate the quality of life of patients. Special clothes or bags should be manufactured to overcome these undesired conditions.
In conclusion, as these complicative issues are resolved, mechanical support devices may get one step closer to replacing heart transplantation.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
EDITORIAL COMMENT
Mehmet Hakan Akay
The short-to-shield phenomenon is a very unique
driveline dysfunction observed in HeartMate II left
ventricular assist device (LVAD) patients. Disruption
of the driveline wiring results in pump stoppage which could be fatal, if not recognized and appropriately
managed in a timely manner. The pump stoppagerelated
pump thrombosis or severe regurgitation
through the outflow graft and pump into the left ventricle would deteriorate hemodynamic status of
the patient. In a retrospective analysis of patients
who underwent HeartMate II LVAD placement
at our institution, there were 14 patients who had
short-to-shield phenomenon. At our institution, any
patients who are suspected to have this phenomenon
are immediately called and admitted to our hospital.
The manufacturer of the device is also notified
immediately and the engineers from the manufacturing
company arrive at our institution to perform subsequent
analysis. During this analysis, they evaluated the
driveline and fixed the issue once recognized. If
driveline cannot be repaired from skin level and out,
then an immediate pump exchange is performed via
subcostal incision with cardiopulmonary bypass or
by off-pump approach.[1,2] There are few reports of
heart transplantation from other centers who have
the ability to get a donor heart in a week or two,
since with ground connected the pump does not have short-to-shield; however, we do not have that short
waiting time and we favor pump exchange in these
patients. Additionally, at our institution, we are very
stringent in our pre-LVAD criteria and ensure that the
patient and the family adhere to our center"s pre-andpost
implantation guidelines. Such contracts allow us
to ensure compliance on the patient"s part.
REFERENCES
1. Jafar M, Gregoric ID, Radovancevic R, Cohn WE, McGuire
N, Frazier OH. Urgent exchange of a HeartMate II left
ventricular assist device after percutaneous lead fracture.
ASAIO J 2009;55:523-4.
2. Cohn WE, Mallidi HR, Frazier OH. Safe, effective off-pump sternal sparing approach for HeartMate II exchange. Ann Thorac Surg 2013;96:2259-61.
Correspondence: Mehmet Hakan Akay, MD. UT Health, ACTAT,
Houston, USA.
Tel: 7134866738 e-mail: mehmet.h.akay@uth.tmc.edu
1) Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B,
Russell SD, et al. Clinical management of continuous-flow
left ventricular assist devices in advanced heart failure.
J Heart Lung Transplant 2010;29:S1-S39.
2) Loforte A, Della Monica PL, Musumeci F. A unique case of
driveline fracture in a continuous-flow mechanical support
device. J Heart Lung Transplant 2011;30:967-8.
3) Stulak JM, Schettle S, Haglund N, Dunlay S, Cowger J, Shah
P, et al. Percutaneous Driveline fracture after implantation of
the HeartMate II left ventricular assist device: How durable
is driveline repair? ASAIO J 2017;63:542-5.